Mucolit Oral Solution 250 mg / 5 ml

/ CTS

Adults including the elderly, and children over the age of 12: Dosage is based upon an initial daily dosage of 2250 mg Carbocisteine in divided doses (15 ml
Mucolit Oral Solution 250mg/5ml, three times a day), reducing to 1500 mg daily in divided doses (10 ml, three times a day) when a satisfactory response is obtained.
Children 2 – 5 years: The usual dose is 1.25 – 2.5 ml four times daily
Children 6 – 12 years: The usual dose is 2.5- 5 ml three times daily

Abnormal, viscid or inspissated mucous secretions in acute or chronic respiratory disease.

Known hypersensitivity, active peptic ulcer, first trimester of pregnancy.

Discontinuing breastfeeding temporarily or withholding the drug while breastfeeding.
See prescribing information for full details.

Rare reports of skin rashes and gastrointestinal bleeding.
See prescribing information for full details.

Pregnancy
There are no available data on Carbocysteine use in pregnant women. No conclusions can be drawn regarding whether
or not Carbocysteine is safe for use during pregnancy. The use of Carbocysteine in pregnant women is not recommended, especially during the first trimester.
Breast-feeding
There are no available data on the presence of Carbocysteine in human milk, milk production, or the effects on the breastfed infant. No conclusions can be drawn regarding whether or not Carbocysteine is safe for use during breastfeeding. The use of Carbocysteine in breastfeeding women is not recommended.